{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:25:38Z","timestamp":1790371538125,"version":"4.1.0"},"reference-count":37,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JEP"],"DOI":"10.2147\/jep.s254334","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T02:56:06Z","timestamp":1590720966000},"page":"107-128","source":"Crossref","is-referenced-by-count":18,"title":["<p>Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia<\/p>"],"prefix":"10.2147","volume":"Volume 12","author":[{"given":"Fatemeh","family":"Pourrajab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Reza","family":"Zare-Khormizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-3753","authenticated-orcid":true,"given":"Seyedhossein","family":"Hekmatimoghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam Sadat","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e12102","DOI":"10.1097\/MD.0000000000012102","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"ref2","first-page":"188","volume":"4","author":"Masoumi-Dehshiri","year":"2014","journal-title":"Iran J Ped Hematol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1142\/S1793984413500037","volume":"3","author":"Hekmatimoghaddam","year":"2013","journal-title":"Nano Life"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.leukres.2010.09.002","volume":"35","author":"Price","year":"2011","journal-title":"Leuk Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11864-017-0456-2","volume":"18","author":"Bose","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1021\/cr900028p","volume":"109","author":"Parker","year":"2009","journal-title":"Chem Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/TCRM.S2941","volume":"4","author":"Harned","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/cncr.28674","volume":"120","author":"Cooper","year":"2014","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1586\/17474086.2014.932687","volume":"7","author":"Al-Hussaini","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-017-0416-0","volume":"10","author":"Hackl","year":"2017","journal-title":"J Hematol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2147\/CMAR.S242479","volume":"12","author":"Pourrajab","year":"2020","journal-title":"Cancer Manag Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/10428190903096719","volume":"50","author":"Wu","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pharmthera.2016.02.003","volume":"160","author":"Gavande","year":"2016","journal-title":"Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2217\/fon.11.2","volume":"7","author":"Thurn","year":"2011","journal-title":"Future Oncol"},{"key":"ref15","first-page":"8581421","volume":"2016","author":"Mody","year":"2016","journal-title":"Case Rep Hematol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1182\/blood.V98.4.913","volume":"98","author":"Laurent","year":"2001","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12967-017-1281-x","volume":"15","author":"Lim","year":"2017","journal-title":"J Transl Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.bcp.2009.06.094","volume":"78","author":"Zhenchuk","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1172\/JCI69739","volume":"124","author":"Navada","year":"2014","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.clml.2012.04.004","volume":"12","author":"Braoudaki","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1182\/blood-2017-04-777722","volume":"130","author":"Magina","year":"2017","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1182\/blood-2002-02-0495","volume":"100","author":"Dervieux","year":"2002","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/med.21437","volume":"37","author":"Zagni","year":"2017","journal-title":"Med Res Rev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2741\/3691","volume":"16","author":"Wanczyk","year":"2011","journal-title":"Front Biosci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/leu.2008.397","volume":"23","author":"Flotho","year":"2009","journal-title":"Leukemia"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1182\/asheducation-2011.1.550","volume":"2011","author":"Gore","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/biof.1264","volume":"43","author":"Hekmatimoghaddam","year":"2017","journal-title":"Biofactors"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.3390\/molecules20033898","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","volume":"31","author":"Prada-Arismendy","year":"2017","journal-title":"Blood Rev"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1658-3876(08)50023-9","volume":"1","author":"Zaidi","year":"2008","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fonc.2018.00092","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1182\/blood-2006-03-009142","volume":"108","author":"Garcia-Manero","year":"2006","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1158\/0008-5472.CAN-06-0080","volume":"66","author":"Gore","year":"2006","journal-title":"Cancer Res"},{"key":"ref35","unstructured":"U.S. Food and Drug Administration. Gemtuzumab ozogamicin: FDA-Approved Drugs. Retrieved from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=761060."},{"key":"ref36","unstructured":"European Medicines Agency. Mylotarg EPAR. Retrieved from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/mylotarg-0."},{"key":"ref37","unstructured":"FDA approves venetoclax in combination for AML in adults; 2020. Retrieved from: https:\/\/www.fda.gov\/drugs\/fda-approves-venetoclax-combination-aml-adults."}],"container-title":["Journal of Experimental Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=58515","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T02:56:13Z","timestamp":1590720973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/molecular-targeting-and-rational-chemotherapy-in-acute-myeloid-leukemi-peer-reviewed-article-JEP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":37,"URL":"https:\/\/doi.org\/10.2147\/jep.s254334","relation":{},"ISSN":["1179-1454"],"issn-type":[{"value":"1179-1454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}